Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-7058 in combination with antitumor drugs in advanced solid tumors
NCT06915142Phase 2Recruiting
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Apr 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-7058 in Advanced Malignant Solid Neoplasm (AMSN), sponsored by Shandong Suncadia Medicine Co., Ltd.. Started Apr 2025; status: recruiting.
02
Drugs
HRS-7058
03
Conditions
Advanced Malignant Solid Neoplasm (AMSN)
Beyond the preview
Go deeper on NCT06915142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06915142.